Abstract:DNA-based immunization, the delivery of plasmid DNA by direct inoculation, is a newly developed method of vaccination. Besides of many advantages, DNA immunization was demonstrated to generate weaker antibody and CTL responses than did protein and live attenuated vaccines, respectively. To circumvent this shortage, several methods were tested such as using different vector, changing injection mode, and co-expressing cytokines, etc. The studies showed that many factors could greatly affect the immune responses to DNA vaccine. The aim of this study is to compare different vectors for the presentation of the HCV E2 to generate immune responses by using DNA-based immunization. Four expression plasmids, with different promoter types and with or without signal sequences were constructed, which encode C-terminally truncated E2 (384-660) with HBV preS1 21-47 tag fused to its N-termini. Transient expression in HeLa cells showed that only recombinant plasmids with signal sequence could be expressed and properly processed, and the product could be secreted into medium. Protein expression level is slightly higher in plasmids with CMV promoter than with EF1alpha promoter. After immunization of C57BL/6 mice, all the recombinant constructs could elicit both anti-preS1 and anti-E2 antibodies. But only pCMV Sec-S1E2t660 with both CMV promoter and signal sequence could induce high-level and long-lasting antibody, showing that it is a good vaccine candidate. Possible reasons for the different immune responses to these constructs were discussed.

Retroviral Vector Mediated HCV E1E2 Envelope Protein Expression in Eukaryotic Cells and Animal Immune Experiment

[Expression of Hepatitis C Virus Envelope Proteins with a Recombinant Baculovirus Expression System].

Expression and Characterization of Hepatitis C Virus E2 Glycoprotein Fused to Hepatitis B Virus Pres1(21-47) Fragment in CHO Cells

Expression of CSFV E2 Envelope Protein Gene in Eukaryotic Cells and Preparation of Monoclonal Antibodies Against CSFV E2 Envelope Protein

Expression of Hepatitis C Virus H Strain Envelope Glycoprotein in Insect Cells

Prokaryotic Expression and Purification of Truncated Hepatitis C Virus Envelope Glycoprotein E2

Expression of Csfv E2 Protein in Eukaryotic Cells and Characterization of Immunity in Animals

Purification and Application of C-terminally Truncated Hepatitis C Virus E1 Proteins Expressed in Escherichia Coli.

Expressing E2 gene of classical swine fever virus Shimen strain in the vein endothelial cells of immortality swine

The Fusion Expression and Purification of HCV Envelop Protein E2 and Preparation of Its Polyclonal Antibody

Expression of HCV Structural Protein in Mammalian Cells

Expression of Structural Proteins of Hepatitis C Virus (HCV) in Mammalian Cells

Construction of an Effective Eukaryotic Bi-Cistronic Expression Vector Containg HCV Internal Ribosome Entry Site

Expression of Truncated Form of HCV Glycoprotein E2 and Assay of Activation of Reporter Genes in Yeast Two-hybrid System

Expression of Hepatitis C Virus E2 Ectodomain in E. Coli and Its Application in the Detection of Anti-E2 Antibodies in Human Sera

Expression of E1 Gene of a Hepatitis C Virus Ine. Coli and Protein Purification

DNA Immunization with Recombinant HCV E2 Expression Plasmids.

Expression of fusion protein EGFP-HBVP22e in HepG2 cells

Effect of Gene Structure of Recombine Plasmid in HCV/E2 Protein Expression

Construction of Eukaryotic Expressional Vector of HCV 5′NCR and Core Gene Fragments and Its Localization in HepG2 Cells

Co-Expression of Hepatitis B Virus Proteins and Green Fluorescent Protein After Eukaryotic Cell in vitro and Hydrodynamics-Based in vivo Transfection